| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | Chief Medical Officer | Common Stock | 252K | $863K | $3.43 | Aug 9, 2024 | Direct |
| Aquestive Therapeutics, Inc. | Chief Medical Officer | Non-Qualified Stock Option (right to buy) | 56.3K | Mar 7, 2024 | Direct | ||
| Aceragen, Inc. | CHIEF MEDICAL OFFICER | Stock Options (Right ot Buy) | 25.4K | Jan 20, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | Aug 9, 2024 | 1 | -$37.1K | 4 | Aug 12, 2024 | Chief Medical Officer |
| AQST | Aquestive Therapeutics, Inc. | Mar 7, 2024 | 2 | $0 | 4 | Mar 11, 2024 | Chief Medical Officer |
| AQST | Aquestive Therapeutics, Inc. | Aug 9, 2023 | 1 | $0 | 4 | Aug 9, 2023 | Chief Medical Officer |
| AQST | Aquestive Therapeutics, Inc. | Jun 26, 2023 | 0 | $0 | 3 | Jun 30, 2023 | CHIEF MEDICAL OFFICER |
| ACGN | Aceragen, Inc. | Jan 20, 2023 | 1 | $0 | 4 | Feb 2, 2023 | CHIEF MEDICAL OFFICER |
| ACGN | Aceragen, Inc. | Jan 17, 2023 | 1 | $0 | 4 | Jan 19, 2023 | Chief Medical Officer |
| IDRA | IDERA PHARMACEUTICALS, INC. | Sep 28, 2022 | 3 | $0 | 4 | Sep 30, 2022 | Chief Medical Officer |
| IDRA | IDERA PHARMACEUTICALS, INC. | Sep 28, 2022 | 0 | $0 | 3 | Sep 30, 2022 | Chief Medical Officer |